Episode 86 - GLP-1 Agonists: A New Era in Weight Management | The Future of Dermatology Podcast
Description
Summary
In this episode of the Future of Dermatology Podcast, Dr. Faranak Kamangar discusses the evolving landscape of dermatology with a focus on incretin medications, particularly GLP-1 agonists. This podcast explores the historical context of these medications, their role in weight management, and the implications for dermatological health. Dr. Kamangar addresses the side effects associated with these treatments, including the phenomenon known as 'Ozempic face,' and offers recommendations for maintaining healthy weight and skin health.
Takeaways
- Incretin medications include GLP-1 agonists and GIPs.
- GLP-1 agonists have been used since 2005 for diabetes.
- Weight loss medications can have significant side effects.
- Rapid weight loss can lead to 'Ozempic face' due to fat loss.
- Maintaining muscle mass is crucial during weight loss.
- Long-term use of weight loss medications may be necessary.
- Lifestyle changes are essential for sustainable weight management.
- Dermatologists should be aware of the metabolic effects of these medications.
- Natural fat in the face is important for youthful appearance.
- Body contouring devices can help target specific fat areas.
Chapters
00:00 - Introduction to Dermatometabolic Series
02:47 - Understanding Incretin Medications
06:02 - The Role of GLP-1 Agonists in Weight Management
09:10 - Exploring Side Effects and Safety Profiles
12:08 - Comparative Effectiveness of Semaglutide and Terzepatide
14:48 - Ozempic Face: Causes and Solutions
21:07 - Recommendations for Healthy Weight Management
United States
